Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724640 | SCV000231369 | uncertain significance | not provided | 2018-07-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724640 | SCV000728548 | benign | not provided | 2020-05-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000619660 | SCV000736666 | likely benign | Cardiovascular phenotype | 2016-08-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001085311 | SCV001016011 | likely benign | Duchenne muscular dystrophy | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330538 | SCV004038113 | benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001833088 | SCV002087711 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2019-06-24 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004537481 | SCV004741114 | likely benign | DMD-related disorder | 2019-09-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |